GW Pharmaceuticals

$145.46
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.89 (-1.28%) Today
$0.00 (0.00%) As of 4:52 PM EDT after-hours

Why Robinhood?

You can buy or sell GWPH and other stocks, options, ETFs, and crypto commission-free!

About GWPH

GW Pharmaceuticals Plc American Depositary Shares, also called GW Pharmaceuticals, is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It offers its lead cannabinoid product, Epidiolex oral solution CV, a pharmaceutical formulation of cannabidiol (CBD) focusing on the treatment of seizures associated with tuberous sclerosis complex. Read More The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom.

Employees
801
Headquarters
Cambridge, Cambridgeshire
Founded
2001
Market Cap
4.47B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
368.75K
High Today
$149.18
Low Today
$144.97
Open Price
$145.70
Volume
296.33K
52 Week High
$196.00
52 Week Low
$90.14

Collections

GWPH News

BenzingaAug 15

Early Success Of CBD Drug Looms Large For The Industry's Future

369
MarketWatchAug 10

Marijuana-derived epilepsy drug doubles sales, sending GW Pharma stock soaring

968
BenzingaAug 8

GW Pharma - Cramer: Epidiolex Maker GW Pharma Is Far From A 'Sketchy' Weed Business

731

GWPH Earnings

-$3.12
-$2.10
-$1.08
-$0.06
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
Actual
Expected Nov 12, After Hours

Popular Stocks

More GWPH News

CNBCAug 7

GW Pharma CEO: More education needed on real health benefits of drugs derived from cannabis

303
BenzingaAug 7

GW Pharma Analysts Raise Estimates After CBD Drug Epidiolex Shows Strong Uptake

159
BenzingaAug 6

GW Pharma Rallies On Strong Q2 Epidiolex Sales, Says European Approval Expected In October

68
BenzingaAug 5

GW Pharma, - The Week Ahead In Cannabis: Cronos And GW Pharma Earnings, Ontario's Second License Lottery

1,235
MarketWatchJul 26

European Medicines Agency gives positive opinion on GW Pharma's cannibidiol drug

776
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.